Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  53 results for ""Respirovirus Infections""

Your Filters

Subject : antiviral agents
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A robust mouse model of HPIV-3 infection and efficacy of GS-441524 against virus-induced lung pathology.

  • Authors : Lin Y; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Virology, Antiviral Drug & Vaccine Research Group, Leuven, Belgium.; Khan M

Subjects: Disease Models, Animal* ; Lung*/Lung*/Lung*/virology ; Lung*/Lung*/Lung*/pathology

  • Source: Nature communications [Nat Commun] 2024 Sep 05; Vol. 15 (1), pp. 7765. Date of Electronic Publication: 2024 Sep 05.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Protective antibodies against human parainfluenza virus type 3 infection.

  • Authors : Boonyaratanakornkit J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Singh S

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*pharmacology ; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*pharmacology ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology

  • Source: MAbs [MAbs] 2021 Jan-Dec; Vol. 13 (1), pp. 1912884.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

C6orf106 is a novel inhibitor of the interferon-regulatory factor 3-dependent innate antiviral response.

  • Authors : Ambrose RL; From the Australian Animal Health Laboratory, Commonwealth Scientific and Industrial Research Organisation (CSIRO) Health and Biosecurity, Geelong, Victoria 3220, Australia and.; Liu YC

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Immunity, Innate/Immunity, Innate/Immunity, Innate/*immunology ; Interferon Regulatory Factor-3/Interferon Regulatory Factor-3/Interferon Regulatory Factor-3/*antagonists & inhibitors

  • Source: The Journal of biological chemistry [J Biol Chem] 2018 Jul 06; Vol. 293 (27), pp. 10561-10573. Date of Electronic Publication: 2018 May 25.Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication

Record details

Read More Add to Saved list
×
Academic Journal

In vitro sensitivity of human parainfluenza 3 clinical isolates to ribavirin, favipiravir and zanamivir.

  • Authors : Smielewska A; Division of Virology, Department of Pathology, University of Cambridge, Addenbrookes Hospital, Cambridge, United Kingdom; PHE - Public Health England Laboratory, Cambridge. Box 236, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, United Kingdom. Electronic address: .

Subjects: Amides/Amides/Amides/*pharmacology ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Parainfluenza Virus 3, Human/Parainfluenza Virus 3, Human/Parainfluenza Virus 3, Human/*drug effects

  • Source: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2018 May; Vol. 102, pp. 19-26. Date of Electronic Publication: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9815671 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model.

  • Authors : Jones BG; Department of Infectious Diseases, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA. Electronic address: .; Hayden RT

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Parainfluenza Virus 2, Human/Parainfluenza Virus 2, Human/Parainfluenza Virus 2, Human/*drug effects ; Parainfluenza Virus 3, Human/Parainfluenza Virus 3, Human/Parainfluenza Virus 3, Human/*drug effects

  • Source: Antiviral research [Antiviral Res] 2013 Nov; Vol. 100 (2), pp. 562-6. Date of Electronic Publication: 2013 Sep 27.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient.

  • Authors : Drozd DR; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington 98195-6175, USA.; Limaye AP

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Lung Transplantation/Lung Transplantation/Lung Transplantation/*adverse effects ; Parainfluenza Virus 3, Human/Parainfluenza Virus 3, Human/Parainfluenza Virus 3, Human/*isolation & purification

  • Source: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2013 Feb; Vol. 15 (1), pp. E28-32. Date of Electronic Publication: 2012 Dec Publisher: Munksgaard Country of Publication: Denmark NLM ID: 100883688 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation.

  • Authors : Chen YB; Bone Marrow Transplant Unit, Massachusetts General Hospital, Boston, MA, USA. ; Driscoll JP

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage ; Recombinant Fusion Proteins/Recombinant Fusion Proteins/Recombinant Fusion Proteins/*administration & dosage ; Respirovirus Infections/Respirovirus Infections/Respirovirus Infections/*drug therapy

  • Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2011 Oct; Vol. 53 (7), pp. e77-80. Date of Electronic Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by α-acylaminoamido groups at the C-4 position using isocyanide-based four-component coupling and biological evaluation as inhibitors of human parainfluenza virus type 1.

  • Authors : Nishino R; Department of Organic Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Shizuoka 422-8526, Japan.; Hayakawa T

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*chemistry ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; N-Acetylneuraminic Acid/N-Acetylneuraminic Acid/N-Acetylneuraminic Acid/*analogs & derivatives

  • Source: Chemical & pharmaceutical bulletin [Chem Pharm Bull (Tokyo)] 2013; Vol. 61 (1), pp. 69-74.Publisher: Pharmaceutical Society of Japan Country of Publication: Japan NLM ID: 0377775 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles.

  • Authors : Cichero E; a Department of Pharmacy , University of Genoa , Genoa , Italy.; Tonelli M

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*pharmacology ; Respiratory Syncytial Viruses/Respiratory Syncytial Viruses/Respiratory Syncytial Viruses/*drug effects

  • Source: Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2017 Dec; Vol. 32 (1), pp. 375-402.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101150203 Publication Model: Print Cited Medium: Internet ISSN: 1475-6374

Record details

Read Online Read More Add to Saved list
×
Academic Journal

TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response.

  • Authors : Yang K; Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.; Shi HX

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*metabolism ; DNA-Binding Proteins/DNA-Binding Proteins/DNA-Binding Proteins/*physiology ; Interferon Regulatory Factor-3/Interferon Regulatory Factor-3/Interferon Regulatory Factor-3/*metabolism

  • Source: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2009 Mar 15; Vol. 182 (6), pp. 3782-92.Publisher: American Association of Immunologists Country of Publication: United States NLM ID: 2985117R Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  53 results for ""Respirovirus Infections""